<p>Note: The p-values of the synergistic drug interaction tests among these drug pairs are larger than 0.05. In each cell, the reported numbers represent relative risk (95% CI) and (m1/n1, m2/n2, m12/n12), where (n1, n2, n12) are sample sizes for drug exposure groups of drug 1 alone, drug 2 alone, and both drugs, respectively; and (m1, m2, m12) are myopathy frequencies for drug exposure groups of drug 1 alone, drug 2 alone, and both drugs, respectively.</p
Statins reduce the risk of major coronary outcomes and all cause mortality. They are generally well ...
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are generally ver...
Introduction: Statin monotherapy is generally well tolerated, with a low frequency of adverse events...
<p>Note: Risk1 and risk2 are myopathy risks for drug 1 and drug 2 respectively. The risk-ratio is ca...
Purpose: To investigate the extent to which clinicians avoid well-established drug-drug interactions...
To investigate the extent to which clinicians avoid well-established drug-drug interactions that cau...
To investigate the extent to which clinicians avoid well-established drug-drug interactions that cau...
Muscular adverse reactions are well known adverse effects of statin therapy. A weaker evidence exist...
Emerging data suggest that the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors ...
Muscular adverse reactions are well known adverse effects of statins. A weaker evidence exists also ...
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are generally wel...
<p>Note: Risk1 and risk2 are myopathy risks for drug 1 and drug 2 respectively. The risk-ratio is ca...
Aims: To investigate the occurrence of myopathy with oral glucose-lowering drugs (OGLDs) and statins...
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are the most widely prescribed ...
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are effective in ...
Statins reduce the risk of major coronary outcomes and all cause mortality. They are generally well ...
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are generally ver...
Introduction: Statin monotherapy is generally well tolerated, with a low frequency of adverse events...
<p>Note: Risk1 and risk2 are myopathy risks for drug 1 and drug 2 respectively. The risk-ratio is ca...
Purpose: To investigate the extent to which clinicians avoid well-established drug-drug interactions...
To investigate the extent to which clinicians avoid well-established drug-drug interactions that cau...
To investigate the extent to which clinicians avoid well-established drug-drug interactions that cau...
Muscular adverse reactions are well known adverse effects of statin therapy. A weaker evidence exist...
Emerging data suggest that the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors ...
Muscular adverse reactions are well known adverse effects of statins. A weaker evidence exists also ...
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are generally wel...
<p>Note: Risk1 and risk2 are myopathy risks for drug 1 and drug 2 respectively. The risk-ratio is ca...
Aims: To investigate the occurrence of myopathy with oral glucose-lowering drugs (OGLDs) and statins...
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are the most widely prescribed ...
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are effective in ...
Statins reduce the risk of major coronary outcomes and all cause mortality. They are generally well ...
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are generally ver...
Introduction: Statin monotherapy is generally well tolerated, with a low frequency of adverse events...